Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified.
Geraghty, Keith, Scott, Michael J · BMC psychology · 2020 · DOI
Quick Summary
This paper examines a UK mental health program called IAPT that offers psychological therapy for conditions with unexplained physical symptoms, including ME/CFS. The authors identified serious problems with how the program treats ME/CFS patients, including using treatments that haven't been proven to work, overstating how many people recover, and not being honest about how many patients drop out. The paper calls for better independent checking of the program and warns that psychology should not be the automatic treatment when doctors don't understand what's causing physical symptoms.
Why It Matters
This study is important because it critically examines how a major government-funded mental health service treats ME/CFS patients and identifies significant methodological and ethical problems. For patients, it validates concerns about being offered psychological treatment without clear evidence it will help and without full transparency about treatment limitations. For researchers and clinicians, it highlights the need for rigorous, independent evaluation of treatments and honest reporting of outcomes.
Observed Findings
- IAPT treatment protocols for medically unexplained symptoms lack proven rationale and weak evidence base
- Recovery claims are exaggerated while dropout rates are under-reported
- Significant risk of misdiagnosis when ME/CFS symptoms are attributed to psychological causes
- Program applies uniform psycho-behavioural therapy without individualizing for patient needs
- Absence of independent oversight and transparent outcome measurement
Inferred Conclusions
- IAPT's application to ME/CFS requires independent evaluation and accountability mechanisms
- Patients must receive full informed consent about treatment rationale and evidence limitations before participating
- Psychological therapy should not be a default treatment when physical causes remain unexplained
- Patients who decline psychological therapy or don't meet criteria need appropriate medical and psychological support
Remaining Questions
- What specific independent oversight mechanisms would best evaluate IAPT outcomes for ME/CFS?
- How should informed consent be structured to ensure patients understand evidence limitations?
What This Study Does Not Prove
This editorial does not prove that psychological therapy is harmful for all ME/CFS patients, nor does it establish that psychological factors play no role in symptom experience. It does not evaluate individual patient outcomes or provide data comparing IAPT to other treatment approaches. The editorial focuses on systemic failings in program evaluation and reporting rather than proving the therapy itself is ineffective in all cases.
- What alternative or complementary treatment approaches should be offered to ME/CFS patients not suited for psychological therapy?
- How can services better integrate medical investigation with psychological support without prematurely attributing physical symptoms to psychological causes?